Method Article
Here, we present a protocol for retrosternal thyroid goiter resection using a thoracoscopic-assisted transcervical approach.
Resecting a large goiter extending into the retrosternal space is challenging, especially when a sternotomy or thoracotomy is required. The transthoracic approach is linked to higher postoperative morbidity, reaching up to 30% when compared to the transcervical approach. Although alternative options like thoracoscopic resection have shown promising results, the morbidity of mediastinal dissection remains a concern. Thoracoscopic-assisted transcervical approach might be a feasible, less invasive alternative. This video outlines the steps and potential pitfalls of the procedure.
The patient is positioned supine with an extended neck. Initially, the endocrine surgeon mobilizes the thyroid gland through cervical access. If a transcervical resection is not feasible, the patient is mobilized into a lateral decubitus position, and a second team thoracoscopically guides the mediastinal tumor through the thoracic inlet. This allows a stepwise controlled transcervical dissection of the retrosternal mass until complete resection is achieved, thus eliminating the need for mediastinal dissection.
To demonstrate the procedure, we present the case of an 84-year-old male with lymph node-positive oncocytic thyroid carcinoma and a large retrosternal goiter extending posteriorly into the mediastinum up to the aortic arch. Thoracoscopic-assisted transcervical resection was performed. The recurrent laryngeal nerve was identified and monitored with a neurostimulation device during dissection. No palsy was noted in the postoperative evaluation. The patient had an uneventful postoperative course and was discharged on the second postoperative day.
Thoracoscopic-assisted transcervical resection of large retrosternal goiter seems a feasible alternative to mitigate risks associated with thoracotomy, sternotomy, or thoracoscopic mediastinal dissection. Potential advantages include decreased postoperative morbidity and length of stay. This technique requires thoracoscopic expertise and may be limited depending on the goiter's size and mediastinal positioning.
A retrosternal goiter represents an entity of abnormal thyroid enlargement, with its largest mass extending through the thoracic inlet into the intrathoracic space1. Therefore, retrosternal goiters differ from nodular goiters anatomically rather than physiopathologically. Triggered by environmental and genetic factors, goiter development is also associated with iodine deficiency, thyroid nodules, Hashimoto's thyroiditis, and Graves' disease. The prevalence of retrosternal goiters varies greatly by region, from 0.02% to 30% and adopted definitions1,2,3,4. Retrosternal goiters typically occur in the anterior mediastinum (80-90%) and more rarely posterior to the trachea or esophagus in the posterior mediastinum. Since anatomical structures limit thyroid tissue expansion except in the inferior part, goiters expand downward through the thoracic inlet4. This might also be triggered by gravity, traction during swallowing, negative pressure, and individual anatomy.
Surgery is indicated for retrosternal goiters with suspected malignancy, compressive symptoms, and cosmetic issues and selectively for hyperthyroid goiters5. Resection of asymptomatic goiters is usually not indicated, although controversial due to malignancy risk and size expansion over the years4,5. Due to their anatomical position, retrosternal goiters present specific challenges during surgical resection. Most goiters can be resected through a transcervical approach; however, a transthoracic approach via sternotomy or thoracotomy may be indicated6. These procedures are clearly linked to higher postoperative morbidity. Therefore, minimally invasive approaches are being investigated to improve outcomes7,8,9,10,11,12. However, the morbidity linked to mediastinal dissection remains a concern.
This article presents an innovative yet simple technique: a thoracoscopic-assisted transcervical approach without mediastinal dissection that might potentially mitigate the risks of conventional techniques. To introduce the technique, a brief background is provided with the following key points: (i) Retrosternal goiter: definition and incidence, (ii) Indication for resection, (iii) Transcervical resection is feasible in >95% of cases, (iv) Transthoracic approaches for larger goiter (linked to higher morbidity, longer length of stay, and higher transfusion rate), (v) Thoracoscopic-assisted transcervical resection as an alternative approach.
To illustrate the procedure technique and pitfalls, we present the case of an 84-year-old male with a large retrosternal goiter on the right side (Figure 1) and an oncocytic thyroid carcinoma on the left side with positive lymph nodes in the cervico-lateral compartment undergoing a thoracoscopic-assisted transcervical thyroidectomy.
The protocol follows the guidelines of Bern University Hospital's human research ethics committee. The patient provided both written and oral consent for the anonymous use of his surgical images.
1. Surgery Part I: Transcervical resection
NOTE: The first step of this procedure involves a thyroidectomy performed in a standard fashion with a transcervical approach. Since the carcinoma is located on the left side, it is common practice to begin on this side.
2. Surgery Part II: Thoracoscopic-assisted transcervical resection
NOTE: The thoracic and cervical surgical team should possess the expertise necessary to manage potential complications associated with the dissection of a retrosternal goiter, such as uncontrolled bleeding in the mediastinum. In this case, an emergency thoracotomy or a thoracoscopic mediastinal dissection might be indicated.
3. Postoperative follow-up
We have adopted this innovative technique since 2021. We always start the resection of retrosternal goiter with a transcervical approach, as the vast majority of retrosternal goiters can be resected this way. If we suspect that a transthoracic approach might be needed, the patient is informed about this possibility, and the thoracic team is notified in advance and ready to step in if necessary.
From January 1, 2021, to December 31, 2023, we performed 481 thyroidectomies at our institution, of which 0.4% (n = 2) required a transthoracic approach. In both cases, a thoracoscopic-assisted transcervical resection was successful. Patients were discharged on the second postoperative day. Postoperative follow-up was uneventful, with no postoperative complications. As a representative example, we present a case of an 84-year-old male with a large retrosternal goiter. Figure 1 shows the CT with venous contrast indicating retrosternal goiter on the transverse (Figure 1A) and coronal planes (Figure 1B). Figure 2 shows the thoracoscopic-assisted transcervical right thyroidectomy with intermittent neuromonitoring of the vagal and recurrent laryngeal nerves.
To our knowledge, no other data on the thoracoscopic-assisted (without mediastinal dissection) approach is available. This is due to the novelty of the technique and the rarity of such procedures (0.3%-4% of thyroidectomies)13.
Testini et al. reported the results of a multicenter analysis of 19,662 thyroidectomies, among which 0.35% (n = 69) involved a transthoracic approach. Retrosternal goiter had higher postoperative morbidity than cervical goiter (35% vs. 23.7%, p < 0.001), and the morbidity was even higher when a transthoracic approach was used (53.5%)13.
Khan et al. reported a comparison from the National Surgical Quality Improvement Program (NSQIP) database between patients undergoing retrosternal goiter resection with a transcervical versus a transthoracic approach. In their analysis, transthoracic approaches were associated with longer lengths of stay (2.4 vs. 1.5 days, p < 0.001), higher rates of unplanned intubation (OR [95% CI] 2.7 [1.17-6.25]), and transfusion (OR [95% CI] 5.56 [2.38-13.0])6.
Thoracoscopic-assisted transcervical resection presents a promising alternative to traditional thoracotomy, sternotomy, or thoracoscopic mediastinal dissection for large retrosternal goiters. This minimally invasive technique might significantly reduce postoperative morbidity, such as surgical site infections and respiratory complications. The avoidance of mediastinal dissection may result in shorter operative times, reduced blood loss, and fewer intraoperative injuries. This effect would be especially beneficial in an elderly and high-risk population. The approach requires a second surgical team experienced in thoracoscopic procedures and the use of a bronchial blocker.
To validate the effectiveness and safety of this technique, larger case series and further studies are warranted. While thoracoscopic-assisted transcervical resection may offer advantages, its applicability might be limited by the size and position of the goiter within the mediastinum, as well as the need for mediastinal lymph node dissection. Careful patient selection and a thorough understanding of the potential limitations are crucial for optimizing outcomes.
Figure 1: Computed tomography with venous contrast. The red arrow indicates retrosternal goiter on the (A) transverse and (B) coronal planes. Please click here to view a larger version of this figure.
Figure 2: Thoracoscopic-assisted transcervical right thyroidectomy. (A) Thoracoscopic view of the retrosternal goiter. (B) The goiter is pushed through the thoracic inlet (C) while the transcervical resection is performed Please click here to view a larger version of this figure.
The great majority of retrosternal goiters can be resected with a transcervical approach13. However, if this is not feasible or in the eventuality of a complication, such as uncontrolled bleeding, the surgeon must be prepared for a bail-out procedure to access the retrosternal part of the goiter. Usually, a thoracotomy or thoracoscopy is used for a retrosternal goiter located in the posterior mediastinum, and a sternotomy is performed for goiter in the anterior mediastinum. Risk factors for thoracic access include malignancy, mediastinal malignant nodes, extension of the goiter below the aortic arch or subcarinal region, history of retrosternal goiter, ectopic thyroid nodule, thyroid tissue density, and goiter located in the posterior mediastinum13,14,15,16.
Sternotomy and thoracotomy are clearly associated with higher postoperative morbidity, up to 30%, including higher transfusion rates, hematoma, hypoparathyroidism, palsy of the recurrent laryngeal nerve, unplanned intubation, and longer hospital stays6,13. It is, however, unclear if part of these complications can solely be explained by the access itself or if they are linked to the anatomical challenges posed by large retrosternal goiters that are not resectable through a transcervical approach. Nevertheless, sternotomy or thoracotomy should be avoided whenever possible without compromising the surgery's safety. Emergent procedures such as thoracoscopic resection or robotic-assisted thoracoscopic resection with mediastinal dissection have been described in case series7,8,9,10,11,12. Although the sample sizes are too small to evaluate their outcomes compared to a transcervical or open thoracic approach, the required mediastinal dissection might still be associated with significant morbidity when compared to the transcervical approach. The present technique offers the advantage of minimally invasive access to the thoracic space with only two trocars and without mediastinal dissection17. The use of a normal endotracheal tube with intermittent desufflation using a bronchial blocker during the thoracoscopic phase is also linked to lower pulmonary complications compared to a double-lumen tube18,19. Further studies are needed to draw conclusions on its associated morbidity. However, lower morbidity than the open thoracic approach might be expected.
Possible limitations of this technique are expected in goiters with a larger anteroposterior dimension than the thoracic inlet, as well as retrosternal goiters localized in the anterior part of the mediastinum. If lymph node metastases are present in the mediastinum, a mediastinal dissection might be necessary. In the present case, no mediastinal lymph nodes were evident on the preoperative imaging.
The authors have no disclosure or conflict of interest.
None
Name | Company | Catalog Number | Comments |
12 mm Balloon Trocar | N/A | N/A | Thoracoscopic part |
Bipolar Forceps | Symmetry Surgical | https://www.aspensurgical.com/Catalog/Products/open-surgery-instruments | Cervical part |
Laparoscopic grasper | Thoracoscopic part | ||
Laparoscopy tower | Karl Storz | https://www.karlstorz.com/us/en/category.htm?cat=1000113577 | Thoracoscopic part |
LigaSure Impact Open Instrument | Medtronic | https://www.medtronic.com/covidien/en-us/support/products/vessel-sealing/ligasure-impact-sealer-divider.html | Cervical part |
NIM 3.0 Systems | Medtronic | https://www.medtronic.com/us-en/healthcare-professionals/products/ear-nose-throat/neuromonitoring/nerve-integrity-monitor-3.html | Neuromonitoring |
Surgical instruments and draping for open surgery | N/A | N/A | Cervical part |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved